Concepedia

Louise Bowman

LB

Statistics

Publications

36

Citations

4.4K

H-Index

26

Active since

2010

Affiliations

University of Oxford(Current)

Medical Research Council

Queen Mary University of London

British Heart Foundation

University of Bristol

Louise Bowman is an author at University of Oxford specializing in medicine, pharmacotherapy, and cardiovascular disease.

Publications per year

2010–2026

36

Publications

36

HPS2-THRIVE randomized placebo-controlled trial in 25 673 high-risk patients of ER niacin/laropiprant: trial design, pre-specified muscle and liver outcomes, and reasons for stopping study treatment

Lixin Jiang, Jemma C. Hopewell, Jing Li et al. · European Heart Journal · 2013 · 673 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +8

Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

Eugenia Abaleke, Mustafa Abbas, Sadia Abbasi et al. · The Lancet · 2021 · 564 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +6

Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial

Obbina Abani, Ali Abbas, Fatima Abbas et al. · The Lancet · 2021 · 521 citations · Full text

Pharmacy, Internal Medicine, Pharmacotherapy +11

The Magic of Randomization versus the Myth of Real-World Evidence

Rory Collins, Louise Bowman, Martin Landray et al. · New England Journal of Medicine · 2020 · 474 citations

Public Health, Biostatistics, Epidemiologic Methods +12

Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

Obbina Abani, Ali Abbas, Fatima Abbas et al. · The Lancet · 2022 · 384 citations · Full text

Life Sciences, Immunology, Pharmacotherapy +14

1–5 of 36